1. Home
  2. RMD vs HLN Comparison

RMD vs HLN Comparison

Compare RMD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RMD
  • HLN
  • Stock Information
  • Founded
  • RMD 1989
  • HLN 2022
  • Country
  • RMD United States
  • HLN United Kingdom
  • Employees
  • RMD N/A
  • HLN N/A
  • Industry
  • RMD Medical/Dental Instruments
  • HLN Package Goods/Cosmetics
  • Sector
  • RMD Health Care
  • HLN Consumer Discretionary
  • Exchange
  • RMD Nasdaq
  • HLN Nasdaq
  • Market Cap
  • RMD 40.7B
  • HLN 48.2B
  • IPO Year
  • RMD 1995
  • HLN N/A
  • Fundamental
  • Price
  • RMD $283.93
  • HLN $9.53
  • Analyst Decision
  • RMD Buy
  • HLN Buy
  • Analyst Count
  • RMD 13
  • HLN 1
  • Target Price
  • RMD $276.82
  • HLN $10.95
  • AVG Volume (30 Days)
  • RMD 1.2M
  • HLN 12.0M
  • Earning Date
  • RMD 07-31-2025
  • HLN 08-19-2025
  • Dividend Yield
  • RMD 0.85%
  • HLN 1.86%
  • EPS Growth
  • RMD 37.43
  • HLN 41.64
  • EPS
  • RMD 9.51
  • HLN 0.23
  • Revenue
  • RMD $5,146,327,000.00
  • HLN $15,096,588,575.00
  • Revenue This Year
  • RMD $8.76
  • HLN $1.93
  • Revenue Next Year
  • RMD $7.16
  • HLN $4.10
  • P/E Ratio
  • RMD $29.85
  • HLN $20.57
  • Revenue Growth
  • RMD 9.84
  • HLN N/A
  • 52 Week Low
  • RMD $199.92
  • HLN $8.86
  • 52 Week High
  • RMD $293.08
  • HLN $11.42
  • Technical
  • Relative Strength Index (RSI)
  • RMD 65.07
  • HLN 42.06
  • Support Level
  • RMD $277.54
  • HLN $9.23
  • Resistance Level
  • RMD $293.08
  • HLN $9.76
  • Average True Range (ATR)
  • RMD 6.83
  • HLN 0.12
  • MACD
  • RMD 0.60
  • HLN 0.01
  • Stochastic Oscillator
  • RMD 71.42
  • HLN 39.86

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

About HLN Haleon plc (Each representing two)

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Share on Social Networks: